Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Revolutionary Advances for Treating Urothelial Carcinoma
EP. 1: Revolutionary Advances for Treating Urothelial Carcinoma
April 22nd 2017
EP. 2: Bladder Cancer: Paradigm Changing Advances in Treatment
April 22nd 2017
EP. 3: Durvalumab FDA Approval for Bladder Cancer
April 22nd 2017
EP. 4: Historic Perspective on Bladder Cancer Treatment
April 22nd 2017
EP. 5: Frontline Atezolizumab for Advanced Bladder Cancer
April 22nd 2017
EP. 6: FDA Approval of Durvalumab for Bladder Cancer
April 22nd 2017
EP. 7: Treatment of Bladder Cancer-Immune Checkpoint Inhibitors
April 22nd 2017
EP. 8: FDA Approval of Durvalumab for Advanced Bladder Cancer
April 22nd 2017
EP. 9: Promising Treatment Options for Advanced Bladder Cancer
April 22nd 2017
EP. 10: Immune Checkpoint Inhibitors for Advanced Bladder Cancer
April 22nd 2017
EP. 11: Durvalumab for Treatment of Advanced Bladder Cancer
April 22nd 2017
EP. 12: Future Treatment Options for Advanced Bladder Cancer
April 22nd 2017
EP. 13: Use of Immune Checkpoint Inhibitors for Bladder Cancer
April 22nd 2017
EP. 14: Highlights of Durvalumab for Advanced Bladder Cancer
April 22nd 2017
EP. 15: Combination Therapies for Advanced Bladder Cancer
April 22nd 2017